期刊文献+

帕金森病患者血清Trx1、PDCD4、AQP4水平与认知功能的关系

The relationship between serum Trx1,PDCD4,AQP4 expression and cognitive function in patients with Parkinson's disease
在线阅读 下载PDF
导出
摘要 目的 探究帕金森病(PD)患者血清硫氧还蛋白1(Trx1)、程序性细胞死亡因子4(PDCD4)、水通道蛋白4(AQP4)水平与认知功能的关系。方法 选取145例PD患者(PD组)为研究对象,依据简易智能状态检查量表(MMSE)将患者分为认知功能障碍(CI)组(43例)和无CI组(102例),再取同期105例健康者作为对照组。收集患者的临床资料并进行分析;酶联免疫吸附试验检测血清中Trx1、PDCD4、AQP4表达;Pearson法分析PD患者血清中Trx1、PDCD4、AQP4水平与CI评分的相关性;多因素Logistic回归分析PD患者发生CI的影响因素;受试者工作特征(ROC)曲线分析血清Trx1、PDCD4、AQP4水平对PD患者发生CI的预测价值。结果 PD组血清Trx1、AQP4水平低于对照组,PDCD4水平高于对照组(P<0.05)。CI组患者PD病程、PDCD4水平均高于无CI组(P<0.05),体质量指数、受教育年限、MMSE评分、蒙特利尔认知评估量表(MoCA)评分、Trx1、AQP4低于无CI组(P<0.05)。PD组患者血清Trx1、AQP4水平与MMSE、MoCA评分呈正相关,血清PDCD4水平与MMSE、MoCA评分呈负相关(P<0.05)。PD病程长、PDCD4水平升高是PD患者发生CI的危险因素,Trx1、AQP4水平升高是PD患者发生CI的保护因素(P<0.05)。血清Trx1、PDCD4、AQP4水平以及联合预测PD患者发生CI的曲线下面积(AUC)分别为0.820、0.741、0.831和0.932,联合预测优于各自单独预测。结论PD患者血清Trx1、AQP4、PDCD4与认知功能密切相关,三者联合对PD患者发生CI的预测价值较高。 Objective To explore the relationship between serum thioredoxin 1(Trx1),programmed cell death factor 4(PDCD4),aquaporin 4(AQP4)expression and cognitive function in patients with Parkinson's disease(PD).Methods A total of 145 PD patients(PD group)were selected as the study subjects,and patients were divided into the cognition impairment(CI)group 43 cases and the no CI group(102 cases)according to the mini-mental state examination(MMSE).Another 105 healthy subjects in the same period were taken as the control group.General patient data were collected and analyzed.The serum expression of Trx1,PDCD4 and AQP4 were detected by ELISA.The correlation between serum levels of Trx1,PDCD4 and AQP4 in PD patients and CI score were analyzed by Pearson method.Multivariate Logistic regression was used to analyze influencing factors of CI in PD patients.The predictive values of serum Trx1,PDCD4 and AQP4 levels for the occurrence of CI in PD patients were analyzed by receiver operating characteristic(ROC)curve.Results Serum levels of Trx1 and AQP4 were lower in the PD group than those of the control group,and PDCD4 was higher in the PD group than that of the control group(P<0.05).In the CI group,PD duration and PDCD4 levels were higher than those of the no CI group(P<0.05),and BMI,years of education,MMSE score,MoCA score,Trx1 and AQP4 were lower than those in the no CI group(P<0.05).In the PD group,serum Trx1 and AQP4 levels were positively correlated with MMSE and MoCA scores,and serum PDCD4 levels were negatively correlated with MMSE and MoCA scores(P<0.05).The long course of disease and increased PDCD4 levels were risk factors for CI in PD patients,while increased Trx1 and AQP4 levels were protective factors for CI in PD patients(P<0.05).Serum Trx1,PDCD4,AQP4 levels and the combined AUC for predicting CI in PD patients were 0.820,0.741,0.831 and 0.932,respectively,and the combined prediction was better than the respective prediction alone.Conclusion Serum Trx1,AQP4 and PDCD4 are closely related to cognitive function,and the combination of the three has high predictive value for CI in PD patients.
作者 翟书鹏 贾航 苗统 魏康康 周国平 ZHAI Shupeng;JIA Hang;MIAO Tong;WEI Kangkang;ZHOU Guoping(Department of Neurosurgery,Nanyang Central Hospital,Nanyang 473004,China)
出处 《天津医药》 2025年第2期146-150,共5页 Tianjin Medical Journal
基金 河南省医学科技攻关项目(LHGJ20191454)。
关键词 帕金森病 认知功能障碍 硫氧还蛋白质类 凋亡调节蛋白质类 水通道蛋白质4 程序性细胞死亡因子4 Parkinson disease cognitive dysfunction thioredoxins apoptosis regulatory proteins aquaporin 4 programmed cell death factor 4
作者简介 翟书鹏(1990),男,主治医师,主要从事神经外科方面研究。E-mail:zsp1990peng@163.com;通信作者:周国平,E-mail:xzqcb81@163.com。
  • 相关文献

参考文献16

二级参考文献130

  • 1罗方接,秦至臻,李小云,曾志明.血清硫氧还蛋白1对判断脑外伤严重程度及其预后的价值[J].武警医学,2020(11):944-947. 被引量:4
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:619
  • 3温洪波,张振馨,牛富生,李凌.北京地区蒙特利尔认知量表的应用研究[J].中华内科杂志,2008,47(1):36-39. 被引量:353
  • 4Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 5Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 6Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 7Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 8Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 9Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 10Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.

共引文献1359

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部